Raymond J. Henley Iii

Array ( [id] => 914708 [patent_doc_number] => 07326733 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-02-05 [patent_title] => 'Methods for increasing bone density' [patent_app_type] => utility [patent_app_number] => 10/453273 [patent_app_country] => US [patent_app_date] => 2003-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 32 [patent_no_of_words] => 10888 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/326/07326733.pdf [firstpage_image] =>[orig_patent_app_number] => 10453273 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6770431 [patent_doc_number] => 20030216371 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-20 [patent_title] => 'Synthetic catalytic free radical scavengers usefuyl as antioxidants for prevention and therapy of disease' [patent_app_type] => new [patent_app_number] => 10/452695 [patent_app_country] => US [patent_app_date] => 2003-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 29862 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20030216371.pdf [firstpage_image] =>[orig_patent_app_number] => 10452695 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 766500 [patent_doc_number] => 07008939 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-03-07 [patent_title] => 'Use of weak opioids and mixed opioid agonists/antagonists for treatment of urinary incontinence' [patent_app_type] => utility [patent_app_number] => 10/448322 [patent_app_country] => US [patent_app_date] => 2003-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3349 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/008/07008939.pdf [firstpage_image] =>[orig_patent_app_number] => 10448322 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7314741 [patent_doc_number] => 20040034105 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-19 [patent_title] => 'Use of 1-phenyl-3-dimethylaminopropane compounds for treatment of urinary incontinence' [patent_app_type] => new [patent_app_number] => 10/448454 [patent_app_country] => US [patent_app_date] => 2003-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6204 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 371 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20040034105.pdf [firstpage_image] =>[orig_patent_app_number] => 10448454 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1002489 [patent_doc_number] => 06908944 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-06-21 [patent_title] => 'Use of 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds for treatment of urinary incontinence' [patent_app_type] => utility [patent_app_number] => 10/448442 [patent_app_country] => US [patent_app_date] => 2003-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4594 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/908/06908944.pdf [firstpage_image] =>[orig_patent_app_number] => 10448442 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7401963 [patent_doc_number] => 20040019075 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-29 [patent_title] => 'New formulation for the parenteral application of crobenetine' [patent_app_type] => new [patent_app_number] => 10/446613 [patent_app_country] => US [patent_app_date] => 2003-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1254 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20040019075.pdf [firstpage_image] =>[orig_patent_app_number] => 10446613 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1073806 [patent_doc_number] => 06838471 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-01-04 [patent_title] => 'Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation' [patent_app_type] => utility [patent_app_number] => 10/446625 [patent_app_country] => US [patent_app_date] => 2003-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 10514 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/838/06838471.pdf [firstpage_image] =>[orig_patent_app_number] => 10446625 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6724549 [patent_doc_number] => 20030206861 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-06 [patent_title] => 'Uses of diterpenoid triepoxides as an antiproliferative agent' [patent_app_type] => new [patent_app_number] => 10/446241 [patent_app_country] => US [patent_app_date] => 2003-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 16167 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0206/20030206861.pdf [firstpage_image] =>[orig_patent_app_number] => 10446241 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1005434 [patent_doc_number] => 06906030 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-06-14 [patent_title] => 'Carbon-substituted diketopiperazine delivery systems' [patent_app_type] => utility [patent_app_number] => 10/443713 [patent_app_country] => US [patent_app_date] => 2003-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5878 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/906/06906030.pdf [firstpage_image] =>[orig_patent_app_number] => 10443713 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 624918 [patent_doc_number] => RE039403 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2006-11-14 [patent_title] => 'Method for supplying bioavailable methionine to a cow' [patent_app_type] => reissue [patent_app_number] => 10/442258 [patent_app_country] => US [patent_app_date] => 2003-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5605 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => -1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/039/RE039403.pdf [firstpage_image] =>[orig_patent_app_number] => 10442258 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7225792 [patent_doc_number] => 20040072882 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-15 [patent_title] => 'Methods to administer epothilone D' [patent_app_type] => new [patent_app_number] => 10/442820 [patent_app_country] => US [patent_app_date] => 2003-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5142 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20040072882.pdf [firstpage_image] =>[orig_patent_app_number] => 10442820 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7437308 [patent_doc_number] => 20040002529 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-01 [patent_title] => 'Pharmaceutical composition' [patent_app_type] => new [patent_app_number] => 10/442874 [patent_app_country] => US [patent_app_date] => 2003-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3814 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20040002529.pdf [firstpage_image] =>[orig_patent_app_number] => 10442874 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1150621 [patent_doc_number] => 06770663 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-08-03 [patent_title] => 'Method for treating fibrotic diseases or other indications utilizing thiazole, oxazole and imidazole compounds' [patent_app_type] => B2 [patent_app_number] => 10/440896 [patent_app_country] => US [patent_app_date] => 2003-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13350 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 1059 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/770/06770663.pdf [firstpage_image] =>[orig_patent_app_number] => 10440896 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7355184 [patent_doc_number] => 20040048839 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-11 [patent_title] => 'Use of delta5-androstene-3beta-ol-7,17-dione in the treatment of lupus erythematosus' [patent_app_type] => new [patent_app_number] => 10/431960 [patent_app_country] => US [patent_app_date] => 2003-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3439 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20040048839.pdf [firstpage_image] =>[orig_patent_app_number] => 10431960 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7306474 [patent_doc_number] => 20040116502 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-17 [patent_title] => 'Treatment of oppositional defiant disorder and conduct disorder with 5-aminoalkyl-4,5,6,7-tetrahydro-4-oxyindolones' [patent_app_type] => new [patent_app_number] => 10/431491 [patent_app_country] => US [patent_app_date] => 2003-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10804 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0116/20040116502.pdf [firstpage_image] =>[orig_patent_app_number] => 10431491 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7674662 [patent_doc_number] => 20040127456 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-01 [patent_title] => 'Prevention and treatment of endotoxemia and related complications associated with surgery' [patent_app_type] => new [patent_app_number] => 10/169628 [patent_app_country] => US [patent_app_date] => 2003-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1859 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0127/20040127456.pdf [firstpage_image] =>[orig_patent_app_number] => 10169628 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6702243 [patent_doc_number] => 20030225123 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-04 [patent_title] => 'Antihypertensive agents and use' [patent_app_type] => new [patent_app_number] => 10/258682 [patent_app_country] => US [patent_app_date] => 2003-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9305 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0225/20030225123.pdf [firstpage_image] =>[orig_patent_app_number] => 10258682 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6702159 [patent_doc_number] => 20030225039 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-04 [patent_title] => 'Method of treatment using bisphosphonic acid' [patent_app_type] => new [patent_app_number] => 10/430007 [patent_app_country] => US [patent_app_date] => 2003-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3149 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0225/20030225039.pdf [firstpage_image] =>[orig_patent_app_number] => 10430007 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7387066 [patent_doc_number] => 20040082641 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-29 [patent_title] => 'Use of glycogen phosphorylase inhibitors for treatment of cardiovascular diseases' [patent_app_type] => new [patent_app_number] => 10/429625 [patent_app_country] => US [patent_app_date] => 2003-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11487 [patent_no_of_claims] => 134 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20040082641.pdf [firstpage_image] =>[orig_patent_app_number] => 10429625 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7387115 [patent_doc_number] => 20040082646 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-29 [patent_title] => 'Use of glycogen phosphorylase inhibitors for treatment of cardiovascular diseases' [patent_app_type] => new [patent_app_number] => 10/429626 [patent_app_country] => US [patent_app_date] => 2003-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7382 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20040082646.pdf [firstpage_image] =>[orig_patent_app_number] => 10429626 [rel_patent_id] =>[rel_patent_doc_number] =>)